Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat_Citations_SUNLONG BIOTECH CO., LTD-杭州圣隆生物科技有限公司

TEL： +86 571 56623320 EMAIL： [email protected]

my cart0
0 products in your cart, total money $0.00.
login
register

All categories

News Center | Citations

Your Position: Home > Citations > Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat

Shipping & Payment

Shipping Policy

Return and refund policy

Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat

SUNLONG BIOTECH / 2024-01-09

Type： serum

Author：Hao Y, Li H, Ge X, Liu Y, Li X, Liu Y, Chen H, Zhang S, Zou J, Huang L, Zhao F, Kang D, De Geest BG, Zhang Z.

Periodical：Angew Chem Int Ed Engl. 2022 Dec 23;61(52):e202214992.

Article source

文章目录[隐藏]

Next:Nanofat functionalized injectable super-lubricating microfluidic microspheres for treatment of osteoarthritis
Previous:An Integration of Network Pharmacology and Experimental Verification to Investigate the Mechanism of Guizhi to Treat Nephrotic Syndrome

User Comment(Total0User Comment Num)

No comment

Call us

+86 571 56623320

Email

[email protected]

Address

Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China

Join Us with

Support

Leave a message